Φορτώνει......
Vaccines for the prevention against the threat of MERS-CoV
First identified in 2012, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV) is listed as a new Category C Priority Pathogen. While the high mortality of MERS-CoV infection is further intensified by potential human-to-human transmissibility, no MERS vaccines are available for human use....
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Expert Rev Vaccines |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097835/ https://ncbi.nlm.nih.gov/pubmed/26985862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14760584.2016.1167603 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|